Skip to content

Frontlight ResearchEarly access

Institution

Clinica Luganese Moncucco

Lugano, SwitzerlandWebsite

1closed trial
502publications (OpenAlex)

Closed trials

Completed
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
NCT02827617· Oncology Institute of Southern Switzerland· Source

Registry name variants (1)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Clinica Luganese Moncucco
Lugano, 6903
1 trial
- NCT02827617Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia

Conditions

Diseases this institution publishes on or runs trials for.

Hyperparathyroidism4 works · 0 trials

Institution data: ROR 04z6xe248 (CC0-1.0)Updated 14 Nov 2026

Report an error